Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wakeling

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Acta Paediatrica (Oslo, Norway : 1992). Supplement|January 8, 2000
The search for the gene for Silver-Russell syndromeG E Moore, S Abu-Amero, E Wakeling, et al.
Journal of Steroid Biochemistry|December 1, 1989
Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell linesF E May, M D Johnson, L R Wiseman, et al.
European Journal of Human Genetics : EJHG|July 1, 1997
Lack of hemizygosity for the insulin-like growth factor I receptor gene in a quantitative study of 33 Silver Russell syndrome probands and their familiesS Abu-Amero, S Price, E Wakeling, et al.
International Journal of Cancer|June 11, 1997
New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145H E Jones, C M Dutkowski, D Barrow, et al.
Cancer Research|December 15, 1989
ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasivenessE W Thompson, D Katz, T B Shima, et al.
Annals of the New York Academy of Sciences|June 12, 1995
Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancerR I Nicholson, J M Gee, D L Manning, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cellsL R Wiseman, M D Johnson, A E Wakeling, et al.
Cancer Research|August 17, 2006
Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor-positive, HER-2/neu-positive breast cancerSuleiman Massarweh, C Kent Osborne, Shou Jiang, et al.
American Journal of Medical Genetics. Part A|April 25, 2015
3p14 deletion is a rare contiguous gene syndrome: report of 2 new patients and an overview of 14 patientsB I Dimitrov, C Ogilvie, D Wieczorek, et al.
The EMBO Journal|September 1, 1993
Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentationF Oberhammer, J W Wilson, C Dive, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Acta Paediatrica (Oslo, Norway : 1992). Supplement|January 8, 2000
The search for the gene for Silver-Russell syndromeG E Moore, S Abu-Amero, E Wakeling, et al.
Journal of Steroid Biochemistry|December 1, 1989
Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell linesF E May, M D Johnson, L R Wiseman, et al.
European Journal of Human Genetics : EJHG|July 1, 1997
Lack of hemizygosity for the insulin-like growth factor I receptor gene in a quantitative study of 33 Silver Russell syndrome probands and their familiesS Abu-Amero, S Price, E Wakeling, et al.
International Journal of Cancer|June 11, 1997
New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145H E Jones, C M Dutkowski, D Barrow, et al.
Cancer Research|December 15, 1989
ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasivenessE W Thompson, D Katz, T B Shima, et al.
Annals of the New York Academy of Sciences|June 12, 1995
Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancerR I Nicholson, J M Gee, D L Manning, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cellsL R Wiseman, M D Johnson, A E Wakeling, et al.
Cancer Research|August 17, 2006
Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor-positive, HER-2/neu-positive breast cancerSuleiman Massarweh, C Kent Osborne, Shou Jiang, et al.
American Journal of Medical Genetics. Part A|April 25, 2015
3p14 deletion is a rare contiguous gene syndrome: report of 2 new patients and an overview of 14 patientsB I Dimitrov, C Ogilvie, D Wieczorek, et al.
The EMBO Journal|September 1, 1993
Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentationF Oberhammer, J W Wilson, C Dive, et al.
Pageof 9